Abstract
Risks and benefits of tumor necrosis factor-alpha inhibitors in the management of psoriatic arthritis: systematic review and metaanalysis of randomized controlled trials.
Amr A Saad, Deborah P M Symmons, Peter R Noyce and Darren M Ashcroft
The Journal of Rheumatology May 2008, 35 (5) 883-890;
Amr A Saad
Deborah P M Symmons
Peter R Noyce
In this issue
The Journal of Rheumatology
Vol. 35, Issue 5
1 May 2008
Risks and benefits of tumor necrosis factor-alpha inhibitors in the management of psoriatic arthritis: systematic review and metaanalysis of randomized controlled trials.
Amr A Saad, Deborah P M Symmons, Peter R Noyce, Darren M Ashcroft
The Journal of Rheumatology May 2008, 35 (5) 883-890;